Insidermedicine Daily News (Video)
Insidermedicine is a daily health and medical video news service created by a leading physicians. Our content library contains videos in many languages including English, Chinese, Spanish, on over 100 different diseases. Joining the likes of the Associated Press and Reuters, Insidermedicine's newstories are featured ...
Insidermedicine is a daily health and medical video news service created by a leading physicians. Our content library contains videos in many languages including English, Chinese, Spanish, on over 100 different diseases. Joining the likes of the Associated Press and Reuters, Insidermedicine's newstories are featured by Google News and The News Room. April 25, 2007 Patients with HIV who are treated with protease inhibitors have an increased risk of heart attack, according to a study published in the New England Journal of Medicine. Combination antiretroviral therapy has had a dramatic effect in reducing illness and death associated with the HIV virus, however an earlier study showed that the risk of heart attacks increased by 17% with every year a patient spent on antiretroviral. It isn’t known, though, whether all antiretroviral drugs carry this risk. The assessment of the role of any specific drug is difficult because patients with HIV usually receive a combination of drugs, and often switch regimens because of the availability of newer substances, adverse events, or drug regimen failure. Previous studies have shown a relationship between the use of protease inhibitors, a class of antiretroviral drug, and cardiovascular disease, but there is little information on the risks associated with another class of antiretroviral therapy called nonnucleoside reverse-transcriptase inhibitors. In this study, more than 23,000 patients infected with the HIV virus were assessed to determine the incidence of heart attack and the association between heart attack and exposure to protease inhibitors or nonnucleoside reverse-transcriptase inhibitors. Confirming the earlier results, the researchers found the risk of having a heart attack increased by 16% per year of exposure to protease inhibitors alone, which is equal to twice the risk over five years. Not such effect was observed with nonnucleoside reverse-transcriptase inhibitors. It is thought that protease inhibitors raise the level of blood lipid, thereby increasing the risk of cardiovascular disease and heart attack. Patients treated with protease inhibitors should have their cholesterol and blood pressure levels monitored, and take steps to reduce their lifestyle-related risk factors. This includes maintaining a healthy weight, eating a low-fat diet rich in fruits in vegetables, and getting regular exercise. Reporting for Insidermedicine, I'm Dr. Susan Sharma.
Show all Visit Show Website http://www.insidermedicine.caRecently Aired
-
HD
Green spaces in cities improve anxiety
(January 7, 2013 - Insidermedicine)From the UK - Green spaces ...
(January 7, 2013 - Insidermedicine)From the UK - Green spaces in cities can have lasting mental health benefits, according to a report published in Environmental Science & Technology. Researchers studied over 1,000 individuals. Participants either moved to green urban areas or less green urban areas. Results showed that those who moved to greener urban areas experienced an instant improvement in their mental health and that these effects were sustained for at least three years. Those who moved to a less green area suffered a drop in their mental health
-
HD
BPA raises risk of cancer in human prostate tissue
(January 7, 2013 - Insidermedicine) From Chicago - A new ...
(January 7, 2013 - Insidermedicine) From Chicago - A new report published in Endocrinology finds that BPA raised risk of cancer in tissue of a human prostate. Researchers first implanted human prostate stem cells into a mouse model. The rodents were then fed a diet for two weeks of either oil or BPA--in amounts equivalent to that consumed by pregnant American women. Results showed that significantly more mice who were fed BPA developed pre-cancerous lesions or prostate cancer, compared to rodents on the oil diet.
-
HD
Factors affecting quality of life in adult strabismus patients
(January 6, 2013 - Insidermedicine) From London -Research published in ...
(January 6, 2013 - Insidermedicine) From London -Research published in the British Journal of Ophthalmology examines factors affecting quality of life in adults with strabismus. Researchers studied over 200 strabismus patients, examining clinical as well as psychosocial variables. 11% of participants were suffering from clinical levels of depression, while 24% were suffering from clinical levels of anxiety. However, pyschosocial factors (such as beliefs and cognitions) more consistently affect quality of life and mood than clinical factors.
-
HD
Meditation can improve symptoms of anxiety, depression
(January 6, 2013 - Insidermedicine) From Baltimore - Meditation can ...
(January 6, 2013 - Insidermedicine) From Baltimore - Meditation can improve symptoms of anxiety and depression, according to a report published in JAMA Internal Medicine. Researchers conducted a meta-analysis of 47 clinical trials and comprised of over 3,500 participants. Results showed that participation in an eight-week training program of mindfulness meditation had improvements in their symptoms of anxiety, depression, and pain. However, there was little evidence of improvement in stress and quality of life.
-
HD
HIV greatly raises risk of heart disease
(January 2, 2013 - Insidermedicine) From Spain - HIV greatly ...
(January 2, 2013 - Insidermedicine) From Spain - HIV greatly raises risk of heart disease, according to a report presented at the annual meeting of the European Association of Cardiovascular Imaging. Researchers studied 65 HIV patients suffering from shortness of breath. Participants had their HIV staged as well as their viral blood load measured. Results showed that a detectable blood viral load raised risk of heart disease nearly twofold.
-
HD
Diabetes meds affect hearts of men and women differently
(January 1, 2013 - Insidermedicine) From St. Louis - Diabetes ...
(January 1, 2013 - Insidermedicine) From St. Louis - Diabetes drugs appear to affect the hearts of men and women differently, according to a report in American Journal of Physiology - Heart and Circulation Physiology. Researchers examined how 3 diabetes treatment regimens affected the hearts of men and women: metformin alone, metformin plus rosiglitazone, and metformin plus Lovaza. Using echocardiograms and PET scans they found that metformin alone had a positive effect on heart metabolism in women, and a detrimental one in men.
-
HD
Obesity linked to greater decline in kidney function
(December 31, 2013 - Insidermedicine) From California - A report ...
(December 31, 2013 - Insidermedicine) From California - A report appearing in the American Journal of Kidney Diseases finds that obesity is associated with a greater decline in kidney function. Nearly 3000 participants were grouped by body mass index into 4 categories by BMI: normal weight, overweight, obese, and extremely obese. At the outset of the study all participants had normal kidney function in the normal range. After following the participants for ten years, all had declines in kidney function. In heavier patients however, this decline was significantly greater and happened more rapidly.
-
HD
US a poor performer in health care spending efficiency
(December 30, 2013 - Insidermedicine) From Montreal - According to ...
(December 30, 2013 - Insidermedicine) From Montreal - According to a new report in the American Journal of Public Health, the United States is a poor performer when it comes to health care spending efficiency. Researchers used data collected over 17 years from 27 high-income countries. Overall the US ranked 22nd in life expectancy gain from 1991 to 2007. Splitting the data by gender, they found that the US ranked 18th for life expectancy gains in men, and 25th for women. A similar gender split was also found in the majority of the other 26 countries studied.
-
HD
Contact lens developed to treat glaucoma
(December 28, 2013 - Insidermedicine) From Boston - A new ...
(December 28, 2013 - Insidermedicine) From Boston - A new contact lens has been developed that can treat glaucoma. Appearing in the journal Biomaterials in January 2014, researchers created a drug-eluting contact lens that can deliver its medication consistently for weeks to months. The lens has a commonly used glaucoma medication, latanoprost, embedded within it, and achieves drug concentrations comparable to daily eye-drop use. The drug is located in the periphery of the lens, and so the lens can be made to also correct refractive errors for both near and far sightedness.
-
HD
New delivery method for treatment of pediatric ALL
(December 26, 2013 - Insidermedicine) From Boston - Researchers from ...
(December 26, 2013 - Insidermedicine) From Boston - Researchers from the Dana-Farber Cancer Institute have developed a new delivery method for chemotherapy to treat pediatric acute lymphoblastic leukemia (ALL). Presented at this years American Society of Hematology meeting, they have developed a reformulation of the standard treatment for ALL, E.coli L-asparaginase, suitable for intravenous delivery instead the standard intramuscular injection. This new IV formulation appears to be less painful than the injection, just as effective, and has a similar risk profile.
